EvaluatioN of ApiXaban in strOke and systemic embolism prevention in patients with non‐valvular atrial fibrillation in clinical practice Setting in France,rationale and design of the NAXOS: SNIIRAM study |
| |
| Authors: | Fabien Picard,Eric Van Ganse,Gregory Ducrocq,Nicolas Danchin,Bruno Falissard,Olivier Hanon,Manon Belhassen,Marine Ginoux,Cinira Lefevre,Fran ois‐Emery Cotte,Isabelle Mah ,Philippe G. Steg |
| |
| Affiliation: | Fabien Picard,Eric Van Ganse,Gregory Ducrocq,Nicolas Danchin,Bruno Falissard,Olivier Hanon,Manon Belhassen,Marine Ginoux,Cinira Lefevre,François‐Emery Cotte,Isabelle Mahé,Philippe G. Steg |
| |
| Abstract: | ![]()
|
| |
| Keywords: | apixaban major bleeding non‐valvular atrial fibrillation non‐vitamin K antagonist oral anticoagulants systemic embolism vitamin‐K antagonists |
|
|
